1 device · 1 company · 2025
Product code NCG: Neuropsychiatric Interpretative Electroencephalograph Assessment Aid
1 device under product code NCG, 2025, from 1 company. Each record carries FDA's decision, the Indications for Use statement verbatim where the public document carries one (1 of 1 here), the regulation, and MAUDE report counts by product code.
Neuropsychiatric Interpretative Electroencephalograph Assessment Aid. 21 CFR 882.1440, Class II. Uses a patient's electroencephalograph (EEG) to provide an interpretation of the patient's neuropsychiatric condition. It is also used only as an assessment aid for a medical condition for which there exists other valid methods of diagnosis." MAUDE held 0 adverse-event reports against this product code as of 2026-10-29; reports are unverified and the code is shared by every device of this type.
Retrieved from FDA public records.
Every device, newest decision first
| Decision | Device | Company | Panel | FDA |
|---|---|---|---|---|
| Ceribell Delirium Monitor SystemK251936 · 510(k) | Ceribell, Inc. | Neurology | database entry |
Every product code in the record, the whole record of FDA AI-enabled medical devices, or what Apodicta does on a medical record.